Protagenic Therapeutics, Inc.\new (PTIX) Return on Assets [ROA] (2014 - 2026)
Protagenic Therapeutics, Inc.\new's Return on Assets [ROA] came in at 169.46% for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 135.60 percentage points from the prior quarter.
Powered by 
Analysis
Protagenic Therapeutics, Inc.\new (PTIX) Return on Assets [ROA] (2014 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Protagenic Therapeutics, Inc.\new's Return on Assets [ROA] was 73.16%, up 424.45 percentage points from FY2025.
- Return on Assets [ROA] carries a five-year change of +148.93 percentage points (FY2021 to FY2026).
- Going back by fiscal year, Return on Assets [ROA] was -351.28% in FY2025, -175.99% in FY2024 (-95.08 pp), -80.91% in FY2023 (-43.67 pp) and -37.24% in FY2022 (+38.53 pp).
- The fiscal Q1 2027 figure represents the highest quarterly Return on Assets [ROA] in data going back to fiscal Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 2.14% |
| 10 | Protagenic Therapeutics, Inc.\new | 1.30 Mn | 1.30 Mn | - | 169.46% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 169.46% |
| Mar 31, 2026 | 33.85% |
| Dec 31, 2025 | -109.31% |
| Mar 31, 2025 | -438.06% |
| Dec 31, 2024 | -275.01% |
| Sep 30, 2024 | -375.71% |
| Jun 30, 2024 | -316.57% |
| Mar 31, 2024 | -174.06% |
| Dec 31, 2023 | -102.51% |
| Sep 30, 2023 | -63.56% |
| Jun 30, 2023 | -47.37% |
| Mar 31, 2023 | -37.08% |
| Dec 31, 2022 | -43.65% |
| Sep 30, 2022 | -44.53% |
| Jun 30, 2022 | -40.37% |
| Mar 31, 2022 | -44.86% |
| Dec 31, 2021 | -39.82% |
| Sep 30, 2021 | -35.04% |
| Jun 30, 2021 | -70.55% |
| Mar 31, 2021 | -621.83% |
API Access
Protagenic Therapeutics, Inc.\new Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PTIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();